Ganciclovir Hikma

Ganciclovir Hikma is an antiviral medication used to treat certain viral infections. It is administered intravenously and is manufactured by Hikma Farmacêutica (Portugal), S.A.

Ganciclovir Hikma is primarily used for the treatment of cytomegalovirus (CMV) infections, particularly in individuals with weakened immune systems. This medication works by slowing the growth of the virus, helping to manage and control the infection. It is often prescribed for patients undergoing organ transplants or those with HIV/AIDS to prevent CMV disease.

Common effects of Ganciclovir Hikma may include fatigue, fever, and changes in blood cell counts. Some individuals might experience nausea, diarrhea, or abdominal pain. It is important to monitor for any signs of allergic reactions or severe side effects and consult a healthcare provider if they occur.

Ganciclovir Hikma should be used with caution in patients with kidney problems or low blood cell counts. Regular blood tests may be required to monitor for potential side effects. Pregnant women and those planning to become pregnant should discuss the risks and benefits with their healthcare provider before using this medication.

Ganciclovir Hikma may interact with other medications, including those that affect kidney function or blood cell production. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect how this medication works.